Source:http://diabetesscholars.org/conference-scholarship/ Scholarships to the Children with Diabetes Friends For Life Conference (CWD) The Diabetes Scholars Foundation provides need based scholarships for families, adults and young adults to attend Children with Diabetes conferences. The conferences are an opportunity for individuals, impacted by diabetes, to increase their overall knowledge of diabetes management, receive up-to-date research information and […]
Category: News (Page 4)
From:http://diatribe.org/jama-paper-breaks-down-medical-research-funding-us The Journal of the American Medical Association (JAMA) recently published a Special Communication paper titled The Anatomy of Medical Research, analyzing medical research funding worldwide between 1994 and 2012. The paper is one of the first and largest of its kind to examine medical research spending on a global scale, and its results identify […]
SourceDHF Blog:http://diabeteshandsfoundation.org/dhf-joins-diabetes-advocacy-alliance/ Diabetes Hands Foundation is incredibly honored to join theDiabetes Advocacy Alliance, an organization with the drive and potential to affect a powerful, positive impact on diabetes and healthcare policy. Diabetes Advocacy Alliance is a 20-member coalition of leading professional societies, nonprofit organizations, and policy change-makers from across the national diabetes landscape. Included among […]
Part of an interesting Dr. blog post that point similarities between diabetes types. When there are too few beta cells to the point that diabetes occurs, whether we are talking about type 1 or type 2, havoc is wreaked on the other 5 hormones secreted by the islet. In those of us lucky enough to […]
Source:http://www.medpagetoday.com/PublicHealthPolicy/HealthPolicy/50424 Heads of the FDA and National Institutes of Health told a Senate panel that the public would be best served if Congress would simply give their agencies the support they need to do their jobs, with less heckling from the sidelines. NIH Director Francis Collins, MD, and outgoing FDA Commissioner Margaret Hamburg, MD, came […]
From QuestDiagnostics: MADISON, N.J.,March 23, 2015/PRNewswire/ People in states that expanded Medicaid under the Affordable Care Act (ACA) are far more likely to be newly identified with diabetes than in states that elected not to expand the public health care program, finds a new study by researchers atQuest Diagnostics(NYSE:DGX). Published online today inDiabetes Care, the […]
Source:http://www.npr.org/blogs/health/2015/03/19/393856788/why-is-u-s-insulin-so-expensive Why Is Insulin So Expensive In The U.S.? Dr. Jeremy Greene sees a lot of patients with diabetes thats out of control. In fact, he says, sometimes their blood sugar is so high that you cant even record the number on their glucometer. Greene, a professor of medicine and history of medicine at Johns […]
Source:http://insulinnation.com/treatment2/medicine-drugs/smart-insulin-reality/ We recently shared news about anew MIT studythat used mice models to test an injectable smart insulin. This insulin activates only when there are traces of excess glucose in the bloodstream, an innovation which could potentially eliminate or lower the risk of hypoglycemia. Such a treatment could revolutionize insulin treatment for Type 1 diabetes. […]
Source:https://glooko.com/wp-content/uploads/2015/03/Glooko-Investment-FINAL-3_17-Website.pdf Palo Alto, Calif. March 17, 2015 Glooko Inc. today announced that it has raised $16.5 Million in Series B financing. The funds will be used to expand the companys FDA-cleared, HIPAA-compliant platform to include device data from insulin pumps, continuous glucose monitoring systems and integration of personalized predictive algorithms. Canaan Partners and Medtronic joined […]
Source:http://www.forbes.com/sites/arleneweintraub/2015/03/19/novo-nordisk-on-diversity-in-diabetes-trials-we-could-do-better/ Novo Nordiskis one of the worlds top makers of diabetes drugssales of its products to treat the disease rose 7% last year to $12.5 billionbut recently the company recognized it had a problem: The racial diversity in its clinical trials did not fully reflect that of the population it serves. We feel we cover […]